| scholarly article | Q13442814 |
| P50 | author | Sandrine Marchand | Q42407690 |
| Olivier Mimoz | Q56549688 | ||
| Marie-Camille Chaumais | Q57089654 | ||
| P2093 | author name string | Kamel Louchahi | |
| Patrick Nicolas | |||
| Olivier Petitjean | |||
| Anne Jacolot | |||
| Claire Judel | |||
| P2860 | cites work | Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study | Q40570367 |
| Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis | Q40585149 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis | Q44570722 | ||
| A comparative study of uranyl nitrate and cisplatin-induced renal failure in rat. | Q45083644 | ||
| Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae. | Q54139323 | ||
| Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia | Q22241905 | ||
| Implications of experimental technique for analysis and interpretation of data from animal experiments: outliers and increased variability resulting from failure of intraperitoneal injection procedures | Q31119263 | ||
| Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment | Q33722082 | ||
| Animal model pharmacokinetics and pharmacodynamics: a critical review | Q34615868 | ||
| Current guidelines for the treatment of severe pneumonia and sepsis | Q36231604 | ||
| Pseudomonas aeruginosa bloodstream infections: how should we treat them? | Q36910009 | ||
| Defining, treating and preventing hospital acquired pneumonia: European perspective | Q37319452 | ||
| Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections | Q37811723 | ||
| Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal models | Q37977581 | ||
| Pharmacodynamics of cefepime in patients with Gram-negative infections | Q39614211 | ||
| Lack of pharmacokinetic interaction between cefepime and amikacin in humans | Q39879612 | ||
| P433 | issue | 2 | |
| P921 | main subject | pneumonia | Q12192 |
| Enterobacter cloacae | Q4038096 | ||
| P304 | page(s) | 129-133 | |
| P577 | publication date | 2012-05-10 | |
| P1433 | published in | Chemotherapy | Q2440355 |
| P1476 | title | Animal model methodology: immunocompetent or leucopenic rats, which is the best? Results from a model of experimental pneumonia due to derepressed cephalosporinase-producing Enterobacter cloacae | |
| P478 | volume | 58 |
Search more.